Dudediligence.

Hyperion DeFi, Inc

HYPDNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

15.3M

on 2026-06-30, from 592K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-80 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

5M10M15M1:80 splitMar2024JunSepDecMar2025JunSepDecMar2026Jun$3.60

Newest

$1.00B

S-3 of 2025-11-17. 1 prospectus supplement filed under it since. S-3 ↗

$500.0M

Agreement of 2025-11-17. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

33.82M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

2.8 quarters

$9.6M on 2026-06-30 ÷ $3.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-05-05Public offering2,777,778$3.60$10.0M424B5 ↗

Also on file: up to $15.0M term loans agreed 2025-02-21 8-K ↗ · up to $15.0M term loans agreed 2025-05-30 8-K ↗ · up to $15.0M term loans agreed 2025-06-17 8-K ↗